Staphylococcal Surgical Site Infections

Infectious Disease Clinics of North America

Volumn 23, Issue 1, 2009, Pages 53-72

  Anderson, Deverick J ^a   Kaye, Keith S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antimicrobial prophylaxis; Epidemiology; Surgical site infection

Indexed keywords

AZTREONAM; CEPHALOSPORIN; DAPTOMYCIN; LINEZOLID; PENICILLIN G; TIGECYCLINE; VANCOMYCIN; VIRULENCE FACTOR;

ANTIBIOTIC PROPHYLAXIS; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; COMPUTER ASSISTED TOMOGRAPHY; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INFECTION RISK; INOCULATION; LEUKOCYTE COUNT; MORBIDITY; MORTALITY; NEUROPATHY; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PATHOGENESIS; PREOPERATIVE CARE; REVIEW; SEROLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; SURGICAL PATIENT; SURGICAL TECHNIQUE; THROMBOCYTOPENIA;

CROSS INFECTION; HUMANS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION; VIRULENCE FACTORS;

EID: 58149178677     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2008.10.004     Document Type: Review

References (121)

1. Graves H.J. National hospital discharge survey: annual summary 1987. Healthy People 2000 Stat Notes 13 (1989) 11
2. Cruse P. Wound infection surveillance. Rev Infect Dis 3 4 (1981) 734-737
3. Wenzel R.P. Health care-associated infections: major issues in the early years of the 21st century. Clin Infect Dis 45 Suppl 1 (2007) S85-S88
4. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 24 5 (1996) 380-388
5. Anderson D.J., Sexton D.J., Kanafani Z.A., et al. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 28 9 (2007) 1047-1053
6. Jernigan J.A. Is the burden of Staphylococcus aureus among patients with surgical-site infections growing?. Infect Control Hosp Epidemiol 25 6 (2004) 457-460
7. Cruse P.J., and Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am 60 1 (1980) 27-40
8. Anderson D.J., Kirkland K.B., Kaye K.S., et al. Underresourced hospital infection control and prevention programs: penny wise, pound foolish?. Infect Control Hosp Epidemiol 28 7 (2007) 767-773
9. Engemann J.J., Carmeli Y., Cosgrove S.E., et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 36 5 (2003) 592-598
10. Kirkland K.B., Briggs J.P., Trivette S.L., et al. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 20 11 (1999) 725-730
11. Wong E.S. Surgical site infections. In: Mayhall C.G. (Ed). Hospital epidemiology and infection control. 3rd edition (2004), Lippincott Williams and Wilkins, Balitmore
12. Mangram A.J., Horan T.C., Pearson M.L., et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 20 4 (1999) 250-78, quiz 279-80
13. Noskin G.A., Rubin R.J., Schentag J.J., et al. The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med 165 15 (2005) 1756-1761
14. McGarry S.A., Engemann J.J., Schmader K., et al. Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol 25 6 (2004) 461-467
15. Cosgrove S.E., Qi Y., Kaye K.S., et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26 2 (2005) 166-174
16. Cosgrove S.E., Sakoulas G., Perencevich E.N., et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36 1 (2003) 53-59
17. Gleason T.G., Crabtree T.D., Pelletier S.J., et al. Prediction of poorer prognosis by infection with antibiotic-resistant gram-positive cocci than by infection with antibiotic-sensitive strains. Arch Surg 134 10 (1999) 1033-1040
18. Mekontso-Dessap A., Kirsch M., Brun-Buisson C., et al. Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis 32 6 (2001) 877-883
19. Sands K., Vineyard G., and Platt R. Surgical site infections occurring after hospital discharge. J Infect Dis 173 4 (1996) 963-970
20. Horan T.C., Gaynes R.P., Martone W.J., et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 13 10 (1992) 606-608
21. Wall D.B., Klein S.R., Black S., et al. A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J Am Coll Surg 191 3 (2000) 227-231
22. Altemeier W.A., Culbertson W.R., and Hummel R.P. Surgical considerations of endogenous infections-sources, types, and methods of control. Surg Clin North Am 48 1 (1968) 227-240
23. Tuazon C.U. Skin and skin structure infections in the patient at risk: carrier state of Staphylococcus aureus. Am J Med 76 5A (1984) 166-171
24. Wiley A.M., and Ha'eri G.B. Routes of infection. A study of using "tracer particles" in the orthopedic operating room. Clin Orthop Relat Res 139 (1979) 150-155
25. Edwards L.D. The epidemiology of 2056 remote site infections and 1966 surgical wound infections occurring in 1865 patients: a four year study of 40,923 operations at Rush-Presbyterian-St. Luke's Hospital, Chicago. Ann Surg 184 6 (1976) 758-766
26. Berkelman R.L., Martin D., Graham D.R., et al. Streptococcal wound infections caused by a vaginal carrier. JAMA 247 19 (1982) 2680-2682
27. Richet H.M., Craven P.C., Brown J.M., et al. A cluster of Rhodococcus (Gordona) Bronchialis sternal-wound infections after coronary-artery bypass surgery. N Engl J Med 324 2 (1991) 104-109
28. Lowry P.W., Blankenship R.J., Gridley W., et al. A cluster of legionella sternal-wound infections due to postoperative topical exposure to contaminated tap water. N Engl J Med 324 2 (1991) 109-113
29. Clegg H.W., Foster M.T., Sanders Jr. W.E., et al. Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. J Infect Dis 147 3 (1983) 427-433
30. Gartenberg G., Bottone E.J., Keusch G.T., et al. Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment. N Engl J Med 299 20 (1978) 1115-1118
31. Weber S., Herwaldt L.A., McNutt L.A., et al. An outbreak of Staphylococcus aureus in a pediatric cardiothoracic surgery unit. Infect Control Hosp Epidemiol 23 2 (2002) 77-81
32. Sheretz R.J., Reagan D.R., Hampton K.D., et al. A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med 124 6 (1996) 539-547
33. Krizek T.J., and Robson M.C. Evolution of quantitative bacteriology in wound management. Am J Surg 130 5 (1975) 579-584
34. Houang E.T., and Ahmet Z. Intraoperative wound contamination during abdominal hysterectomy. J Hosp Infect 19 3 (1991) 181-189
35. James R.C., and Macleod C.J. Induction of staphylococcal infections in mice with small inocula introduced on sutures. Br J Exp Pathol 42 (1961) 266-277
36. Elek S.D., and Conen P.E. The virulence of Staphylococcus pyogenes for man: a study of the problems of wound infection. Br J Exp Pathol 38 6 (1957) 573-586
37. Arbeit R.D., and Dunn R.M. Expression of capsular polysaccharide during experimental focal infection with Staphylococcus aureus. J Infect Dis 156 6 (1987) 947-952
38. Froman G., Switalski L.M., Speziale P., et al. Isolation and characterization of a fibronectin receptor from Staphylococcus aureus. J Biol Chem 262 14 (1987) 6564-6571
39. Switalski L.M., Patti J.M., Butcher W., et al. A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol Microbiol 7 1 (1993) 99-107
40. Mayberry-Carson K.J., Tober-Meyer B., Smith J.K., et al. Bacterial adherence and glycocalyx formation in osteomyelitis experimentally induced with Staphylococcus aureus. Infect Immun 43 3 (1984) 825-833
41. Kasper D.L. Bacterial capsule-old dogmas and new tricks. J Infect Dis 153 3 (1986) 407-415
42. Rogolsky M. Nonenteric toxins of Staphylococcus aureus. Microbiol Rev 43 3 (1979) 320-360
43. Dossett J.H., Kronvall G., Williams Jr. R.C., et al. Antiphagocytic effects of staphylococcal protein A. J Immunol 103 6 (1969) 1405-1410
44. Dellinger E.P. Surgical infections and choice of antibiotics. In: Sabiston D.C. (Ed). Textbook of surgery. 15th edition (1997), W.B. Saunders Co, Philadelphia
45. Kawabata S., Morita T., Iwanaga S., et al. Enzymatic properties of staphylothrombin, an active molecular complex formed between staphylocoagulase and human prothrombin. (Tokyo). J Biochem 98 6 (1985) 1603-1614
46. Aasen A.O. The proenzyme functional inhibition index. A new parameter for evaluation of the severely injured and septic patient. Acta Chir Scand Suppl 522 (1985) 211-231
47. Aasen A.O., and Wang J.E. Mediator responses in surgical infections. Surg Infect (Larchmt) 7 Suppl 2 (2006) S3-S4
48. Wang J.E., Dahle M.K., Yndestad A., et al. Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat. Crit Care Med 32 2 (2004) 546-552
49. Kernodle D.S., Classen D.C., Burke J.P., et al. Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections. JAMA 263 7 (1990) 961-966
50. Kernodle D.S., Voladri R.K., and Kaiser A.B. Beta-lactamase production diminishes the prophylactic efficacy of ampicillin and cefazolin in a guinea pig model of Staphylococcus aureus wound infection. J Infect Dis 177 3 (1998) 701-706
51. Kaye K.S., Schmit K., Pieper C., et al. The effect of increasing age on the risk of surgical site infection. J Infect Dis 191 7 (2005) 1056-1062
52. Zerr K.J., Furnary A.P., Grunkemeier G.L., et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 63 2 (1997) 356-361
53. Lilienfeld D.E., Vlahov D., Tenney J.H., et al. Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. Am J Infect Control 16 1 (1988) 3-6
54. Nagachinta T., Stephens M., Reitz B., et al. Risk factors for surgical-wound infection following cardiac surgery. J Infect Dis 156 6 (1987) 967-973
55. Sorensen L.T., Horby J., Friis E., et al. Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol 28 8 (2002) 815-820
56. Post S., Betzler M., von Ditfurth B., et al. Risks of intestinal anastomoses in Crohn's disease. Ann Surg 213 1 (1991) 37-42
57. Berard F., and Gandon J. Postoperative wound infections: the influence of ultraviolet irradiation of the operating room and of various other factors. Ann Surg 160 Suppl 1 (1964) 1-192
58. Pessaux P., Msika S., Atalla D., et al. Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: a multivariate analysis based on a prospective multicenter study of 4718 patients. Arch Surg 138 3 (2003) 314-324
59. Mishriki S.F., Law D.J., and Jeffery P.J. Factors affecting the incidence of postoperative wound infection. J Hosp Infect 16 3 (1990) 223-230
60. Seropian R., and Reynolds B.M. Wound infections after preoperative depilatory versus razor preparation. Am J Surg 121 3 (1971) 251-254
61. Belda F.J., Aguilera L., Garcia de la Asuncion J., et al. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA 294 16 (2005) 2035-2042
62. Greif R., Akca O., Horn E.P., et al. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group. N Engl J Med 342 3 (2000) 161-167
63. Melling A.C., Ali B., Scott E.M., et al. Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. Lancet 358 9285 (2001) 876-880
64. El-Maallem H., and Fletcher J. Effects of surgery on neutrophil granulocyte function. Infect Immun 32 1 (1981) 38-41
65. Clardy C.W., Edwards K.M., and Gay J.C. Increased susceptibility to infection in hypothermic children: possible role of acquired neutrophil dysfunction. Pediatr Infect Dis 4 4 (1985) 379-382
66. American Institute of Architects. Guidelines for design and construction of hospital and health care facilities (1996), American Institute of Architects Press, Washington, DC
67. Ayliffe G.A. Role of the environment of the operating suite in surgical wound infection. Rev Infect Dis 13 Suppl 10 (1991) S800-S804
68. Latham R., Lancaster A.D., Covington J.F., et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 22 10 (2001) 607-612
69. Gandhi G.Y., Nuttall G.A., Abel M.D., et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 146 4 (2007) 233-243
70. Morain W.D., and Colen L.B. Wound healing in diabetes mellitus. Clin Plast Surg 17 3 (1990) 493-501
71. Hill G.E., Frawley W.H., Griffith K.E., et al. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 54 5 (2003) 908-914
72. Ross H. Postoperative wound infection with methicillin-resistant staphylococci in general surgical patients. Aust N Z J Surg 55 1 (1985) 13-17
73. Manian F.A., Meyer P.L., Setzer J., et al. Surgical site infections associated with methicillin-resistant Staphylococcus aureus: do postoperative factors play a role?. Clin Infect Dis 36 7 (2003) 863-868
74. Dodds Ashley E.S., Carroll D.N., Engemann J.J., et al. Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 38 11 (2004) 1555-1560
75. Anderson D.J., Chen L.F., Schmader K.E., et al. Poor functional status predicts surgical site infection due to methicillin-resistant Staphylococcus Aureus. Infect Control Hosp Epidemiol 29 (2008) 832-839
76. Classen D.C., Evans R.S., Pestotnik S.L., et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 326 5 (1992) 281-286
77. Kernodle D.S., and Kaiser A.B. Surgical and trauma related infections. vol. 2. 5th edition (2000), Churchill Livingstone, New York
78. Antimicrobial prophylaxis in surgery. Med Lett Drugs Ther 39 1012 (1997) 97-101
79. Ehrenkranz N.J. Antimicrobial prophylaxis in surgery: mechanisms, misconceptions, and mischief. Infect Control Hosp Epidemiol 14 2 (1993) 99-106
80. Nichols R.L. Surgical antibiotic prophylaxis. Med Clin North Am 79 3 (1995) 509-522
81. McDonald M., Grabsch E., Marshall C., et al. Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg 68 6 (1998) 388-396
82. Nichols R.L. Antibiotic prophylaxis in surgery. J Chemother 1 3 (1989) 170-178
83. Page C.P., Bohnen J.M., Fletcher J.R., et al. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg 128 1 (1993) 79-88
84. DiPiro J.T., Cheung R.P., Bowden Jr. T.A., et al. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg 152 5 (1986) 552-559
85. Harbarth S., Samore M.H., Lichtenberg D., et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 101 25 (2000) 2916-2921
86. Bratzler D.W., and Hunt D.R. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 43 3 (2006) 322-330
87. Bratzler D.W., and Houck P.M. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38 12 (2004) 1706-1715
88. Dellinger E.P., Hausmann S.M., Bratzler D.W., et al. Hospitals collaborate to decrease surgical site infections. Am J Surg 190 1 (2005) 9-15
89. Institute for Healthcare Improvement. A resource from the Institute of Healthcare Improvement. Available at:. www.ihi.org Accessed January 31, 2008
90. Perl T.M., and Golub J.E. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S aureus nasal carriage. Ann Pharmacother 32 1 (1998) S7-S16
91. Kluytmans J.A., Mouton J.W., Ijzerman E.P., et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 171 1 (1995) 216-219
92. Garibaldi R.A. Prevention of intraoperative wound contamination with chlorhexidine shower and scrub. J Hosp Infect 11 Suppl B (1988) 5-9
93. Hayek L.J., Emerson J.M., and Gardner A.M. A placebo-controlled trial of the effect of two preoperative baths or showers with chlorhexidine detergent on postoperative wound infection rates. J Hosp Infect 10 2 (1987) 165-172
94. Kaiser A.B., Kernodle D.S., Barg N.L., et al. Influence of preoperative showers on staphylococcal skin colonization: a comparative trial of antiseptic skin cleansers. Ann Thorac Surg 45 1 (1988) 35-38
95. Rotter M.L., Larsen S.O., Cooke E.M., et al. A comparison of the effects of preoperative whole-body bathing with detergent alone and with detergent containing chlorhexidine gluconate on the frequency of wound infections after clean surgery. The European Working Party on Control of Hospital Infections. J Hosp Infect 11 4 (1988) 310-320
96. Leigh D.A., Stronge J.L., Marriner J., et al. Total body bathing with 'Hibiscrub' (chlorhexidine) in surgical patients: a controlled trial. J Hosp Infect 4 3 (1983) 229-235
97. Lynch W., Davey P.G., Malek M., et al. Cost-effectiveness analysis of the use of chlorhexidine detergent in preoperative whole-body disinfection in wound infection prophylaxis. J Hosp Infect 21 3 (1992) 179-191
98. Segers P., Speekenbrink R.G., Ubbink D.T., et al. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA 296 20 (2006) 2460-2466
99. Cimochowski G.E., Harostock M.D., Brown R., et al. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 71 5 (2001) 1572-1578 [discussion 1578-9]
100. Kluytmans J.A., Mouton J.W., VandenBergh M.F., et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 17 12 (1996) 780-785
101. Perl T.M., Cullen J.J., Wenzel R.P., et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 346 24 (2002) 1871-1877
102. Perl T.M. Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis. Surgery 134 5 Suppl (2003) S10-S17
103. Miller M.A., Dascal A., Portnoy J., et al. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 17 12 (1996) 811-813
104. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 44 RR-12 (1995) 1-13
105. Bolon M.K., Morlote M., Weber S.G., et al. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis 38 10 (2004) 1357-1363
106. Stevens D.L., Bisno A.L., Chambers H.F., et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41 10 (2005) 1373-1406
107. Karra R., McDermott L., Connelly S., et al. Risk factors for 1-year mortality after postoperative mediastinitis. J Thorac Cardiovasc Surg 132 3 (2006) 537-543
108. Lewis R.T. Soft tissue infections. World J Surg 22 2 (1998) 146-151
109. Weigelt J., Kaafarani H.M., Itani K.M., et al. Linezolid eradicates MRSA better than vancomycin from surgical-site infections. Am J Surg 188 6 (2004) 760-766
110. Gerson S.L., Kaplan S.L., Bruss J.B., et al. Hematologic effects of linezolid: summary of clinical experience. Antimicrobial Agents Chemotheremother 46 8 (2002) 2723-2726
111. Arbeit R.D., Maki D., Tally F.P., et al. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 38 12 (2004) 1673-1681
112. Ellis-Grosse E.J., Babinchak T., Dartois N., et al. The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam. Clin Infect Dis 41 Suppl 5 (2005) S341-S353
113. Zimmerli W., Trampuz A., and Ochsner P.E. Prosthetic-joint infections. N Engl J Med 351 16 (2004) 1645-1654
114. El Oakley R.M., and Wright J.E. Postoperative mediastinitis: classification and management. Ann Thorac Surg 61 3 (1996) 1030-1036
115. Brandt C.M., Sistrunk W.W., Duffy M.C., et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 24 5 (1997) 914-919
116. Raymond D.P., Pelletier S.J., Crabtree T.D., et al. Surgical infection and the aging population. Am Surg 67 9 (2001) 827-832 [discussion 832-23]
117. Mangram A.J., Horan T.C., Pearson M.L., et al. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 27 2 (1999) 97-132 quiz 133-4 [discussion 196]
118. Forse R.A., Karam B., MacLean L.D., et al. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 106 4 (1989) 750-756 [discussion 756-7]
119. Haley R.W., Culver D.H., Morgan W.M., et al. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol 121 2 (1985) 206-215
120. Pryor K.O., Fahey III T.J., Lien C.A., et al. Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA 291 1 (2004) 79-87
121. Kurz A., Sessler D.I., and Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 334 19 (1996) 1209-1215